Clinical Trial

Preservation Vs. Dissection of No. 253 Lymph Nodes of Robotic Resection for Mid/Low Rectal Cancer

Name: Preservation Vs. Dissection of No. 253 Lymph Nodes of Robotic Resection for Mid/Low Rectal Cancer — clinical trial record (NCT06956976)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: REAL2

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

In this study, patients with middle or low rectal cancer will receive robotic radical resection, and will be randomly assigned to receive inferior mesenteric artery lymph nodes dissection or preservation. The 3-year disease-free survival rates of these two surgical approaches will be compared.

Trial Details

NCT Number	NCT06956976
Lead Sponsor	Fudan University
Conditions	Rectal Cancer
Enrollment	1,596 participants
Start Date	2025-06-01
Primary Completion	2031-06-01 (estimated)
Study Completion	2031-06-01 (estimated)
Updated on ClinicalTrials.gov	2025-05-04